The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
A giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
The FTC's first report drew a strong response from the PBM sector, with lawsuits filed in both directions. The FTC has accused the big three of operating a "perverse drug rebate system," while the ...
The industry has come under scrutiny by the Federal Trade Commission. Its first report was released last year. It shows that PBMs profit at the expense of patients and independent pharmacies with ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Responding to the FTC report, the Pharmaceutical Care Management ... One lawmaker who has been deeply critical of the PBM sector, Rep Earl L. “Buddy” Carter (R-GA), who is a pharmacist by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback